2020
DOI: 10.1016/j.transci.2020.102732
|View full text |Cite
|
Sign up to set email alerts
|

Defining critical antibody titre in column agglutination method to guide fetal surveillance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 12 publications
1
4
0
1
Order By: Relevance
“…We noticed a large disparity between titers obtained by CTT and GMA (in some cases, four dilutions: CTT = 2 and GMA = 32). Three to eight dilutions greater in GMA than in CTT were likewise reported by other authors when analyzing alloimmunized patients (Krishnan et al 2020;Novaretti et al 2003). Nonetheless, equivalent levels or one to two differences in dilution by the two methods were also detected (Finck et al 2013;Flesiopoulou et al 2020).…”
Section: Discussionsupporting
confidence: 76%
See 1 more Smart Citation
“…We noticed a large disparity between titers obtained by CTT and GMA (in some cases, four dilutions: CTT = 2 and GMA = 32). Three to eight dilutions greater in GMA than in CTT were likewise reported by other authors when analyzing alloimmunized patients (Krishnan et al 2020;Novaretti et al 2003). Nonetheless, equivalent levels or one to two differences in dilution by the two methods were also detected (Finck et al 2013;Flesiopoulou et al 2020).…”
Section: Discussionsupporting
confidence: 76%
“…In cases of titers smaller than 16 to 32, it is usually not correlated to adverse perinatal outcomes. It requires antenatal supervision, but less mandatory distinguishing between alloimmunization and anti-D (Krishnan et al 2020). Criteria such as these do not discriminate antibody source, since it is not possible to exclude an alloimmunized pregnant woman with low titers.…”
Section: Discussionmentioning
confidence: 99%
“…Three to eight dilutions greater in GMA than in CTT were likewise reported by other authors when analyzing alloimmunized patients. [14,15] Nonetheless, equivalent levels or one to two differences in dilution by the two methods were also detected. [16,17] Although it is not possible to differentiate through CTT or GMA which type of antibody is being titrated (whether from anti-D prophylaxis or due to alloimmunization) [18] the results of this study may be useful to corroborate this discernment.…”
Section: Discussionmentioning
confidence: 92%
“…In cases of titers smaller than 16 to 32, it is usually not correlated to adverse perinatal outcomes. It requires antenatal supervision, but less mandatory distinguishing between alloimmunization and anti-D. [14] Criteria such as these do not discriminate antibody source, since it is not possible to exclude an alloimmunized pregnant woman with low titers. On the other hand, in cases of titers higher than 64 in GMA and 8-16 in CTT there is a high probability of being an alloimmunization, since these levels were not reached in the titration of anti-D. [19] It is also important to monitor titers throughout pregnancy, re-analyzing samples after 3-4 weeks (whenever possible in parallel with previous sample), since if antibody were prophylactic, it is likely titer has declined, as demonstrated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation